Wakamoto Pharmaceutical Co.,Ltd. will postpone the full-year financial results announcement for the fiscal year ending March 31, 2020, which was scheduled for May 14, 2020. Reason for postponing financial results announcement Due to the issuance of an emergency declaration due to the spread of new coronavirus infection, the audit procedures related to financial operations are delayed. As a result, it is difficult to finalize the settlement of accounts on the originally planned schedule. Scheduled date of financial results announcement The date of announcement of financial results is undecided at this time and will be announced as soon as it is finalized. Impact on business performance company is currently scrutinizing the impact on full-year results for the fiscal year ending March 31, 2020, but will promptly announce if any corrections are needed.